Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Tarning

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
The Lancet. Infectious Diseases|July 27, 2019
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic studyRob W van der Pluijm, Mallika Imwong, Nguyen Hoang Chau, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Science Translational Medicine|February 8, 2023
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malariaDennis O Odera, James Tuju, Kennedy Mwai, et al.
Lancet (London, England)|March 15, 2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trialRob W van der Pluijm, Rupam Tripura, Richard M Hoglund, et al.
The New England Journal of Medicine|July 31, 2014
Spread of artemisinin resistance in Plasmodium falciparum malariaElizabeth A Ashley, Mehul Dhorda, Rick M Fairhurst, et al.
Plos Medicine|September 12, 2024
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trialWilliam H K Schilling, Mavuto Mukaka, James J Callery, et al.
Malaria Journal|June 22, 2018
Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Albino Bobogare, Benedikt Ley, et al.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
The Lancet. Infectious Diseases|July 27, 2019
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic studyRob W van der Pluijm, Mallika Imwong, Nguyen Hoang Chau, et al.
The Lancet. Child & Adolescent Health|September 27, 2024
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Elizabeth N Allen, et al.
Science Translational Medicine|February 8, 2023
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malariaDennis O Odera, James Tuju, Kennedy Mwai, et al.
Lancet (London, England)|March 15, 2020
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trialRob W van der Pluijm, Rupam Tripura, Richard M Hoglund, et al.
The New England Journal of Medicine|July 31, 2014
Spread of artemisinin resistance in Plasmodium falciparum malariaElizabeth A Ashley, Mehul Dhorda, Rick M Fairhurst, et al.
Plos Medicine|September 12, 2024
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trialWilliam H K Schilling, Mavuto Mukaka, James J Callery, et al.
Malaria Journal|June 22, 2018
Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working GroupKamala Thriemer, Albino Bobogare, Benedikt Ley, et al.
BMC Medicine|April 19, 2015
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data, Martin A Adjuik, Richard Allan, et al.
Pageof 25